Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ralph Edwards

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Drug Safety|September 18, 2016
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase<sup>®</sup>Rebecca E Chandler, Kristina Juhlin, Jonas Fransson, et al.
Drug Safety|July 6, 2016
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Linda Härmark, June Raine, Hubert Leufkens, et al.
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysisKristina Star, Noha Iessa, Noor B Almandil, et al.
Expert Opinion on Biological Therapy|March 27, 2013
Pharmacovigilance and biosimilars: considerations, needs and challengesNicole Casadevall, I Ralph Edwards, Thomas Felix, et al.
Drug Safety|October 5, 2013
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidanceAnjan K Banerjee, Sally Okun, I Ralph Edwards, et al.
Drug Safety|June 3, 2015
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of PharmacovigilancePriya Bahri, Alexander N Dodoo, Brian D Edwards, et al.
Drug Safety|January 4, 2017
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety AlertsCarrie E Pierce, Khaled Bouri, Carol Pamer, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Pharmacoepidemiology and Drug Safety|May 2, 2007
Guidelines for submitting adverse event reports for publicationWilliam N Kelly, Felix M Arellano, Joanne Barnes, et al.
Drug Safety|August 31, 2014
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculumJürgen Beckmann, Ulrich Hagemann, Priya Bahri, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Drug Safety|September 18, 2016
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase<sup>®</sup>Rebecca E Chandler, Kristina Juhlin, Jonas Fransson, et al.
Drug Safety|July 6, 2016
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?Linda Härmark, June Raine, Hubert Leufkens, et al.
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysisKristina Star, Noha Iessa, Noor B Almandil, et al.
Expert Opinion on Biological Therapy|March 27, 2013
Pharmacovigilance and biosimilars: considerations, needs and challengesNicole Casadevall, I Ralph Edwards, Thomas Felix, et al.
Drug Safety|October 5, 2013
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidanceAnjan K Banerjee, Sally Okun, I Ralph Edwards, et al.
Drug Safety|June 3, 2015
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of PharmacovigilancePriya Bahri, Alexander N Dodoo, Brian D Edwards, et al.
Drug Safety|January 4, 2017
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety AlertsCarrie E Pierce, Khaled Bouri, Carol Pamer, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Pharmacoepidemiology and Drug Safety|May 2, 2007
Guidelines for submitting adverse event reports for publicationWilliam N Kelly, Felix M Arellano, Joanne Barnes, et al.
Drug Safety|August 31, 2014
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculumJürgen Beckmann, Ulrich Hagemann, Priya Bahri, et al.
Pageof 10